Osteoporosis is a condition which causes increased bone weakness. A new clinical study found Denosumab drug to be safe in postmenopausal osteoporosis.

In addition, women who crossed over from 3 years of placebo to 3 years of denosumab experienced no increase in adverse effects compared with women treated for the initial 3 years.
"All of this is consistent with an excellent safety and tolerability profile for denosumab treatment for osteoporosis," said Dr. Nelson Watts, lead author of the study results published in Journal of Bone and Mineral Research. The authors noted that, especially in older women on long-term treatment, many if not all adverse events could be called "life events"--things that would have happened whether or not the person was participating in a clinical trial.
Source-Eurekalert